Lux Research updates nano index

Jan. 6, 2006 — Lux Research, a nanotechnology research and advisory firm, announced a quarterly update to its Lux Nanotech Index.

Index components are split into two groups — nanotech specialists and end-use incumbents. Specialists account for 75 percent of the weighted index, while end-use incumbents account for 25 percent.

In the nanotech specialists category, the company added Arrowhead Research and removed SkyePharma. Lux said in a press release that Arrowhead now met its inclusion criteria while SkyPharma’s focus on nanoparticulate drug solubilization has steadily declined.

In the end-use incumbents category, the company added Toyota and Intel and removed GM and NEC. Lux said Toyota is better positioned to pursue next-generation nanotech applications in automotive than GM. It said Intel has been added because it increasingly focuses on new innovations like carbon nanotube-based electronics, but that NEC’s leadership position has eroded because proposed nano-based products have taken more time than expected.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.